Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
2.540
+0.265 (11.65%)
Sep 2, 2025, 10:48 AM - Market open
Entero Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 0 | 0.16 | 3.71 | 1.36 | 8.25 | 6.06 | Upgrade |
Cash & Short-Term Investments | 0 | 0.16 | 3.71 | 1.36 | 8.25 | 6.06 | Upgrade |
Cash Growth | -99.33% | -95.60% | 172.34% | -83.48% | 36.07% | 3348.39% | Upgrade |
Other Receivables | - | - | - | 0.09 | - | 0.55 | Upgrade |
Receivables | - | - | - | 0.09 | - | 0.55 | Upgrade |
Prepaid Expenses | 0.14 | 0.15 | 1.24 | 1.96 | 1.18 | 1.26 | Upgrade |
Other Current Assets | 83.17 | 83.17 | - | - | - | - | Upgrade |
Total Current Assets | 83.32 | 83.48 | 4.96 | 3.41 | 9.42 | 7.87 | Upgrade |
Property, Plant & Equipment | - | 0.13 | 0.21 | 0.3 | 0.41 | 0.09 | Upgrade |
Goodwill | 1.68 | 1.68 | 1.68 | 1.68 | 1.91 | 2.05 | Upgrade |
Other Intangible Assets | - | - | - | - | - | 2.88 | Upgrade |
Other Long-Term Assets | 0.06 | 0.12 | 0.03 | 0.04 | 0.04 | 0.03 | Upgrade |
Total Assets | 85.06 | 85.41 | 6.88 | 5.44 | 11.79 | 12.92 | Upgrade |
Accounts Payable | 3.3 | 2.96 | 0.55 | 0.72 | 2.71 | 1.56 | Upgrade |
Accrued Expenses | 0.42 | 0.25 | 0.83 | 0.32 | 0.39 | 0.13 | Upgrade |
Short-Term Debt | 0.7 | - | 0.61 | 0.6 | 0.64 | 0.55 | Upgrade |
Current Portion of Leases | 0.14 | 0.08 | 0.07 | 0.07 | 0.08 | 0.06 | Upgrade |
Other Current Liabilities | 25.13 | 24.25 | 1.07 | 0.77 | 8.48 | 13.25 | Upgrade |
Total Current Liabilities | 29.68 | 27.55 | 3.13 | 2.48 | 12.3 | 15.55 | Upgrade |
Long-Term Leases | - | 0.06 | 0.15 | 0.21 | 0.31 | 0.02 | Upgrade |
Other Long-Term Liabilities | - | - | - | - | 7 | - | Upgrade |
Total Liabilities | 29.68 | 27.61 | 3.28 | 2.7 | 19.61 | 15.56 | Upgrade |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade |
Additional Paid-In Capital | 198.35 | 198.51 | 187.93 | 171.28 | 147.31 | 93.84 | Upgrade |
Retained Earnings | -204.65 | -202.39 | -184.33 | -168.53 | -153.9 | -95.37 | Upgrade |
Comprehensive Income & Other | - | - | - | - | -1.22 | -1.11 | Upgrade |
Total Common Equity | -6.3 | -3.88 | 3.6 | 2.74 | -7.82 | -2.64 | Upgrade |
Shareholders' Equity | 55.38 | 57.8 | 3.6 | 2.74 | -7.82 | -2.64 | Upgrade |
Total Liabilities & Equity | 85.06 | 85.41 | 6.88 | 5.44 | 11.79 | 12.92 | Upgrade |
Total Debt | 0.84 | 0.14 | 0.83 | 0.88 | 1.03 | 0.63 | Upgrade |
Net Cash (Debt) | -0.83 | 0.02 | 2.88 | 0.48 | 7.22 | 5.43 | Upgrade |
Net Cash Growth | - | -99.20% | 502.02% | -93.36% | 32.86% | - | Upgrade |
Net Cash Per Share | -0.52 | 0.02 | 25.73 | 40.03 | - | - | Upgrade |
Filing Date Shares Outstanding | 1.59 | 1.59 | 0.68 | 0.03 | - | - | Upgrade |
Total Common Shares Outstanding | 1.59 | 1.58 | 0.52 | 0.02 | - | - | Upgrade |
Working Capital | 53.64 | 55.93 | 1.82 | 0.93 | -2.88 | -7.68 | Upgrade |
Book Value Per Share | -3.96 | -2.45 | 6.92 | 165.36 | - | - | Upgrade |
Tangible Book Value | -7.98 | -5.56 | 1.92 | 1.06 | -9.73 | -7.57 | Upgrade |
Tangible Book Value Per Share | -5.02 | -3.51 | 3.69 | 63.80 | - | - | Upgrade |
Machinery | - | 0.06 | 0.06 | 0.06 | 0.06 | 0.03 | Upgrade |
Leasehold Improvements | - | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.